Preclinical Biomarkers of Central LBDs
ResearchersClinicians
This research article, published in the Journal of Clinical Neurology (2026), examines preclinical biomarkers of central Lewy body diseases (LBDs). The study presents tri-phasic curves and predictive models for identifying individuals at risk before clinical symptoms emerge.
Understanding these biomarkers is crucial for early detection and potential intervention in diseases such as Parkinson disease and dementia with Lewy bodies.
Key Takeaways
- Identifies preclinical biomarkers for central Lewy body diseases before symptoms emerge
- Presents tri-phasic curves and predictive models for early risk identification
- Advances the possibility of preventive intervention in Parkinson disease and dementia with Lewy bodies